Latest otitis Stories
Millions of children are treated with antibiotics for ear infections each year in the US. In fact, an ear infection is one of the most common reasons kids end up going to a doctor and receiving antibiotics.
SAN DIEGO, June 8, 2011 /PRNewswire/ -- Otonomy, Inc., a developer of innovative therapeutics for diseases and disorders of the ear, today announced positive results for OTO-201, a sustained release gel formulation of the antibiotic ciprofloxacin, in multiple preclinical studies evaluating the treatment of middle ear effusion (fluid) at the time of tympanostomy tube placement surgery.
Children with chronic inflammation of the middle ear can experience changes in their sense of taste, and these changes may be related to childhood obesity.
Harvard School of Public Health (HSPH) researchers and colleagues from Research Institute for a Tobacco Free Society have found that a reduction in secondhand smoking in American homes was associated with fewer cases of otitis media, the scientific name for middle ear infection.
13therapeutics, Inc., a bio-pharmaceutical company that develops peptides to treat a variety of inflammatory and auto-immune system diseases, announced today that the company has completed a Type B pre-investigational new drug (Pre-IND) meeting with the U.S.
A history of ear tubes to treat infections does not appear to adversely affect children with cochlear implants, regardless of whether the tubes are left in place or removed before implantation.
SAN DIEGO, Feb. 17 /PRNewswire/ -- Otonomy, Inc. today announced that the U.S.
Strides in improving the nation's air quality over the past ten years may be a factor in fewer cases of ear infections (otitis media) in children. These results are according to new research presented at the 2009 American Academy of Otolaryngology-Head and Neck Surgery Foundation (AAO-HNSF) Annual Meeting & OTO EXPO, in San Diego, CA.
RALEIGH, N.C., June 2 /PRNewswire/ -- Arbor Pharmaceuticals ("Arbor"), a specialty pharmaceutical company focused exclusively on pediatric medicine, announced today that the company has launched ZINOTIC ES as a new treatment option for Acute Otitis Externa (AOE).